Mind Medicine Inc (NAS:MNMD)
$ 8.19 -0.78 (-8.7%) Market Cap: 600.59 Mil Enterprise Value: 438.17 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Q4 2023 Mind Medicine (MindMed) Inc Earnings Call Transcript

Feb 28, 2024 / 01:00PM GMT
Release Date Price: $5.35 (-3.78%)
Operator

Good morning. And welcome to the Mind Medicine full year 2023 financial results and corporate update conference call. Currently, all participants are in listen-only mode. This call is being webcast live on the investors and media section of Mind Med's website at mindmed.co and a recording will be available after the call. For opening remarks, I would like to introduce Rob Barrow, CEO of Mind Med. Please go ahead.

Rob Barrow;MindMed;Inc.;CEO
Mind Medicine

()-

Thank you. And good morning, everyone. Welcome to our full year 2023 financial results and corporate update conference call. The press release reporting our financial results is available in the investors and media section of our website. And our annual report on Form 10-K for the year ended December 31, 2023 is being filed today with the Securities and Exchange Commission.

During today's call, we will be making certain forward-looking statements including without limitation statements about the potential safety efficacy and regulatory and clinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot